Berglund, Johan <br/><br/>
Safety, immunogenicity, and antibody persistence following an investigational Streptococcus pneumoniae and Haemophilus influenzae triple-protein vaccine in a phase 1 randomized controlled study in healthy adults.  [electronic resource] 

 -  Clinical and vaccine immunology : CVI  Jan 2014 
 - 56-65 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1556-679X 
<br/><br/><label>Standard No.: </label>10.1128/CVI.00430-13  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--administration & dosage<br/>Adolescent<br/>Adult<br/>Antibodies, Bacterial--blood<br/>CD4-Positive T-Lymphocytes--immunology<br/>Drug Combinations<br/>Drug-Related Side Effects and Adverse Reactions--epidemiology<br/>Female<br/>Haemophilus Vaccines--administration & dosage<br/>Humans<br/>Male<br/>Pneumococcal Vaccines--administration & dosage<br/>Polysorbates--administration & dosage<br/>Squalene--administration & dosage<br/>Vaccination--adverse effects<br/>Vaccines, Combined--administration & dosage<br/>Vaccines, Subunit--administration & dosage<br/>Vaccines, Synthetic--administration & dosage<br/>Young Adult<br/>alpha-Tocopherol--administration & dosage